Jay S. Duker

CIK 1630864 · President and CEO · last filed 2026-03-24

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.32M

Companies

4

Total Filings

40

Lifetime Open-Market Net

$29.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EYPT President and CEO 178,417 $13.03 $2.32M $29.2K 30 2026-03-24
Carisma Therapeutics Inc. (SESN) Delisted Director 40,000 $12.58 $503.0K $0 5 2022-06-24
EyePoint, Inc. (PSDV) Delisted Director $0 2 2017-12-19
Carisma Therapeutics Inc. (EBIO) Delisted Director $0 3 2017-05-23

Recent Filings · Page 2 of 4

40 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-02-28 EYPT Gift (G) $0 EDGAR
2024-02-22 EYPT Gift (G) $0 EDGAR
2024-02-13 EYPT Mixed +8,434 -$101.8K EDGAR
2024-01-09 EYPT Mixed +14,265 -$133.2K EDGAR
2023-07-12 EYPT Grant (A) $0 EDGAR
2023-06-22 EYPT Grant (A) $0 EDGAR
2023-02-13 EYPT Mixed +7,819 -$17.3K EDGAR
2023-01-10 EYPT Grant (A) $0 EDGAR
2022-11-03 EYPT Mixed +10,779 -$24.3K EDGAR
2022-09-09 EYPT Grant (A) $0 EDGAR
Showing 1120 of 40
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.